m+Medelevator.RU
← Поиск публикаций
Journal of computer assisted tomography · 2026

Diagnostic Value of HRCT and Non-EPI DWI-MRI in Middle Ear Cholesteatoma: Accuracy and Preoperative Impact.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Huimin Xu, Gang Gao, Xinhong Lu, Songqun Hu, Jiaxin Jin, Yaojun Wang

Аннотация

OBJECTIVE: To compare the diagnostic performance of high-resolution computed tomography (HRCT) and non-echo-planar diffusion-weighted magnetic resonance imaging (non-EPI DWI-MRI) for middle ear cholesteatoma and to assess the added value of their combined use in preoperative evaluation.

METHODS: Imaging data sets from 85 subjects (65 with surgically or histopathologically confirmed cholesteatoma, 20 controls) were retrospectively analyzed. HRCT, non-EPI DWI-MRI, and combined HRCT+DWI-MRI interpretations were compared against reference standards. Diagnostic metrics included sensitivity, specificity, accuracy, localization error, and interobserver agreement (κ).

RESULTS: HRCT demonstrated high sensitivity (95.4%) for detecting bony erosions and ossicular abnormalities, whereas non-EPI DWI-MRI showed greater specificity (85.0%) in distinguishing cholesteatoma from other soft tissues. The combined approach yielded optimal diagnostic performance (sensitivity 93.8%, specificity 92.0%, accuracy 93.2%) and the lowest localization error (mean 1.8 mm). Interobserver agreement was excellent (κ=0.88).

CONCLUSION: High-resolution computed tomography and non-echo-planar diffusion-weighted MRI provide complementary diagnostic information in the evaluation of middle ear cholesteatoma. Their combined interpretation may improve diagnostic confidence and radiologic assessment of lesion extent; however, the direct impact on surgical outcomes requires further prospective validation.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты